For STEMI patients who have undergone PCI with coronary ... and thrombotic thrombocytopenic purpura (TTP). These drugs include abciximab, eptifibatide and tirofiban. Glycoprotein IIb/IIIa ...

Our American Heart Month coverage wraps up tonight with a look at some of the most deadly cardiovascular issues and how ...

treatment and procedural characteristics, there were no significant differences between the 325 mg and the 162 mg groups in the composite end point of mortality, myocardial infarction or stroke at ...

The FDA has approved TNKase, a new, fast-acting stroke treatment that dissolves blood clots more efficiently, marking a significant advancement in stroke therapy and clot-busting technology.

For over two decades, a ‘treatment-risk paradox’ has been described in older adults with cardiovascular disease, with ...

The following is a summary of "Low-dose dobutamine stress myocardial contrast echocardiography for evaluating myocardial ...

For patients with either NSTEMI or STEMI, American College of Cardiology/American Heart Association (ACC/AHA) guidelines recommend that intravenous unfractionated heparin (UFH) be dosed by weight ...

Guidance around complete revascularization and intracoronary imaging is strengthened, and Impella gets a recommendation.

Two distinct treatment pathways exist for the treatment of unstable angina/non-STEMI: the “early invasive” strategy and the “ischemia-guided” strategy (formerly known as “initial ...